Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 05:36:13 +0200Mon, 24 Jun 2024 16:48:00 +0200Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 19, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ocrevusHuman medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 19, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ocrevusMon, 24 Jun 2024 16:48:00 +0200Human medicineOcrevus : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-4043-steps-after_en.pdfOcrevus : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-4043-steps-after_en.pdfMon, 24 Jun 2024 16:35:00 +0200Human medicine